Traphagen Investment Advisors LLC Abb Vie Inc. Transaction History

Traphagen Investment Advisors LLC

  • $868 Million
  • Q3 2024

A detailed history of Traphagen Investment Advisors LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Traphagen Investment Advisors LLC holds 9,694 shares of ABBV stock, worth $1.7 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
9,694
Previous 9,763 0.71%
Holding current value
$1.7 Million
Previous $1.67 Million 14.34%
% of portfolio
0.22%
Previous 0.21%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$163.84 - $199.33 $11,304 - $13,753
-69 Reduced 0.71%
9,694 $1.91 Million
Q2 2024

Jul 23, 2024
SELL
$154.79 - $180.76 $9,287 - $10,845
-60 Reduced 0.61%
9,763 $1.67 Million
Q1 2024

May 15, 2024
BUY
$159.82 - $182.1 $1.57 Million - $1.79 Million
9,823 New
9,823 $1.79 Billion
Q4 2023

Jun 17, 2024
SELL
$137.6 - $154.97 $13,484 - $15,187
-98 Reduced 1.0%
9,725 $1.51 Billion
Q3 2023

Jun 17, 2024
BUY
$133.59 - $154.65 $667 - $773
5 Added 0.05%
9,828 $1.47 Billion
Q1 2023

Jun 17, 2024
BUY
$144.61 - $166.54 $41,503 - $47,796
287 Added 6.43%
4,752 $757 Million
Q4 2022

Jun 17, 2024
SELL
$138.31 - $165.87 $741,064 - $888,731
-5,358 Reduced 54.55%
4,465 $722 Million
Q2 2022

Jun 17, 2024
SELL
$137.62 - $174.96 $879,391 - $1.12 Million
-6,390 Reduced 65.05%
3,433 $826 Million
Q1 2022

Jun 17, 2024
SELL
$131.98 - $163.75 $329,818 - $409,211
-2,499 Reduced 42.13%
3,433 $858 Million
Q4 2021

Jun 17, 2024
SELL
$107.43 - $135.93 $418,010 - $528,903
-3,891 Reduced 39.61%
5,932 $803 Million
Q3 2021

Jun 17, 2024
BUY
$106.4 - $120.78 $4,256 - $4,831
40 Added 0.69%
5,869 $633 Million
Q2 2021

Jun 17, 2024
BUY
$105.21 - $117.21 $30,300 - $33,756
288 Added 5.2%
5,829 $657 Million
Q1 2021

Jun 17, 2024
SELL
$102.3 - $112.62 $438,048 - $482,238
-4,282 Reduced 43.59%
5,541 $600 Million
Q4 2020

Jun 17, 2024
SELL
$80.49 - $108.67 $4,668 - $6,302
-58 Reduced 1.04%
5,537 $593 Million
Q3 2020

Jun 17, 2024
BUY
$85.91 - $100.83 $33,676 - $39,525
392 Added 7.53%
5,595 $490 Million
Q2 2020

Jun 17, 2024
SELL
$73.37 - $98.18 $338,969 - $453,591
-4,620 Reduced 47.03%
5,203 $511 Million
Q1 2020

Jun 17, 2024
SELL
$64.5 - $97.79 $301,279 - $456,777
-4,671 Reduced 47.55%
5,152 $393 Million
Q4 2019

Jun 17, 2024
SELL
$72.13 - $90.25 $343,771 - $430,131
-4,766 Reduced 48.52%
5,057 $448 Million
Q3 2019

Jun 17, 2024
SELL
$62.98 - $75.72 $300,162 - $360,881
-4,766 Reduced 48.52%
5,057 $383 Million
Q2 2019

Jun 17, 2024
SELL
$65.7 - $83.98 $303,139 - $387,483
-4,614 Reduced 46.97%
5,209 $379 Million
Q1 2019

Jun 17, 2024
SELL
$77.14 - $90.79 $356,078 - $419,086
-4,616 Reduced 46.99%
5,207 $420 Million

Others Institutions Holding ABBV

# of Institutions
3,852
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Traphagen Investment Advisors LLC Portfolio

Follow Traphagen Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traphagen Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traphagen Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email